Bookmark and Share

Compound Summary for: CID 60149

sertindole

Also known as: SerLect, Serdolect, Sertindol, Sertindolum, Sertindol [INN-Spanish], Sertindolum [INN-Latin], 106516-24-9, sertindole hydrochloride
Molecular Formula: C24H26ClFN4O   Molecular Weight: 440.940843   InChIKey: GZKLJWGUPQBVJQ-UHFFFAOYSA-N
Sertindole, a neuroleptic, is one of the newer antipsychotic medications available. Serdolect is developed by the Danish pharmaceutical company H. Lundbeck. Like the other atypical antipsychotics, it has activity at dopamine and serotonin receptors in the brain. It is used in the treatment of schizophrenia. It is classified chemically as a phenylindole derivative. It was first marketed in 1996 in several European countries before being withdrawn two years later because of numerous cardiac adverse effects. It has once again been approved and should soon be available on the French and Australian market.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _